Co-Diagnostics Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Co-Diagnostics.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Medical Equipment earnings growth | 16.2% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 15 Mar 2024 |
Recent future growth updates
Recent updates
One Co-Diagnostics, Inc. (NASDAQ:CODX) Analyst Just Slashed Their Estimates By A Consequential 14%
May 18A Look At The Intrinsic Value Of Co-Diagnostics, Inc. (NASDAQ:CODX)
Apr 14Co-Diagnostics: Hold Thesis Remains Well Intact
Sep 07Co-Diagnostics stock sinks ~37% after hours on Q2 results miss, hurt by lower volumes
Aug 11Co-Diagnostics spikes on shipments of monkeypox test
Jul 11Estimating The Intrinsic Value Of Co-Diagnostics, Inc. (NASDAQ:CODX)
Jul 06Co-Diagnostics: Well Priced, Long-Term Value Remains Too Distant
Jun 21Co-Diagnostics: Where's Eikon?
Apr 03Co-Diagnostics, Inc. (NASDAQ:CODX) Shares Could Be 29% Below Their Intrinsic Value Estimate
Mar 28Co-Diagnostics: Swinging For The Fences
Jan 24Does Co-Diagnostics (NASDAQ:CODX) Deserve A Spot On Your Watchlist?
Dec 28Why Co-Diagnostics Is A Solid Covid-19 Play
Aug 19Co-Diagnostics, Inc.'s (NASDAQ:CODX) Share Price Boosted 42% But Its Business Prospects Need A Lift Too
Aug 14Co-Diagnostics gets CE marking for direct saliva SARS-CoV-2 test
Jun 18Co-Diagnostics: No One-Hit Wonder
Jun 04This Just In: Analysts Are Boosting Their Co-Diagnostics, Inc. (NASDAQ:CODX) Outlook for This Year
May 18These Analysts Just Made A Huge Downgrade To Their Co-Diagnostics, Inc. (NASDAQ:CODX) EPS Forecasts
Mar 30US$22.33: That's What Analysts Think Co-Diagnostics, Inc. (NASDAQ:CODX) Is Worth After Its Latest Results
Mar 27Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2024 | 6 | -31 | N/A | N/A | 1 |
12/31/2023 | 7 | -35 | -23 | -22 | N/A |
9/30/2023 | 5 | -43 | -23 | -21 | N/A |
6/30/2023 | 7 | -38 | -15 | -14 | N/A |
3/31/2023 | 12 | -32 | -8 | -7 | N/A |
12/31/2022 | 34 | -14 | 5 | 7 | N/A |
9/30/2022 | 53 | 15 | 14 | 15 | N/A |
6/30/2022 | 78 | 28 | 25 | 26 | N/A |
3/31/2022 | 101 | 40 | 36 | 37 | N/A |
12/31/2021 | 98 | 37 | 40 | 41 | N/A |
9/30/2021 | 105 | 42 | 55 | 56 | N/A |
6/30/2021 | 96 | 46 | 52 | 53 | N/A |
3/31/2021 | 93 | 51 | 41 | 42 | N/A |
12/31/2020 | 75 | 42 | 27 | 28 | N/A |
9/30/2020 | 48 | 28 | 6 | 7 | N/A |
6/30/2020 | 26 | 10 | -3 | -3 | N/A |
3/31/2020 | 2 | -6 | -6 | -5 | N/A |
12/31/2019 | 0 | -6 | -6 | -6 | N/A |
9/30/2019 | 0 | -6 | -5 | -5 | N/A |
6/30/2019 | 0 | -6 | -5 | -5 | N/A |
3/31/2019 | 0 | -6 | -5 | -4 | N/A |
12/31/2018 | 0 | -6 | -4 | -4 | N/A |
9/30/2018 | 0 | -6 | -4 | -4 | N/A |
6/30/2018 | 0 | -8 | -5 | -4 | N/A |
3/31/2018 | 0 | -8 | -4 | -4 | N/A |
12/31/2017 | 0 | -7 | -3 | -3 | N/A |
9/30/2017 | 0 | -6 | N/A | -3 | N/A |
6/30/2017 | 0 | -3 | N/A | -2 | N/A |
3/31/2017 | N/A | -2 | N/A | -1 | N/A |
12/31/2016 | N/A | -2 | N/A | -1 | N/A |
9/30/2016 | 0 | -2 | N/A | -1 | N/A |
12/31/2015 | 0 | -2 | N/A | -2 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if CODX's forecast earnings growth is above the savings rate (2.3%).
Earnings vs Market: Insufficient data to determine if CODX's earnings are forecast to grow faster than the US market
High Growth Earnings: Insufficient data to determine if CODX's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if CODX's revenue is forecast to grow faster than the US market.
High Growth Revenue: Insufficient data to determine if CODX's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if CODX's Return on Equity is forecast to be high in 3 years time